Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow limitation and abnormal inflammatory response of the lungs to inhaled noxious particles or gases. We used a proteomic approach with 2-DE followed by MALDI TOF-MS analyses in order to identify potential biomarkers in the early stages of the disease: GOLD stage mild and moderate.
Plasma Proteomic Signatures in Early Chronic Obstructive Pulmonary Disease / Baralla, A., Fois, A.G., Sotgiu, E., Zinellu, E., Mangoni, A.A., Sotgia, S., Zinellu, A., Pirina, P., Carru, C.. - In: PROTEOMICS. CLINICAL APPLICATIONS. - ISSN 1862-8346. - (2018), p. 1700088. [10.1002/prca.201700088]
Plasma Proteomic Signatures in Early Chronic Obstructive Pulmonary Disease
Baralla, Angela;Fois, Alessandro G;Sotgiu, Elisabetta;Zinellu, Elisabetta;Mangoni, Arduino A;Sotgia, Salvatore;Zinellu, Angelo;Pirina, Pietro;Carru, Ciriaco
2018-01-01
Abstract
Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow limitation and abnormal inflammatory response of the lungs to inhaled noxious particles or gases. We used a proteomic approach with 2-DE followed by MALDI TOF-MS analyses in order to identify potential biomarkers in the early stages of the disease: GOLD stage mild and moderate.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
